TrialClinical drug investigation2022

Safety, Tolerability, and Pharmacokinetics of Ropanicant (SUVN-911), a Novel Alpha4 Beta2 Nicotinic Acetylcholine Receptor (α4β2 nAChR) Antagonist, in Healthy Adult and Elderly Subjects.

Ramakrishna Nirogi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.